In this issue:
African-specific molecular taxonomy of prostate cancer
Rezvilutamide vs bicalutamide for high-volume, metastatic HSPC
Patient-reported outcomes with olaparib + abiraterone for mCRPC
Intensity-modulated radiotherapy for prostate cancer
Metastasis-directed therapy in oligometastatic prostate cancer
Biochemical failure is not a surrogate endpoint for OS
ADT + radical local therapy for oligometastatic prostate cancer
PSMA-radioguided RARP and ePLND
Neoadjuvant novel hormonal therapy + prostatectomy for high-risk prostate cancer
MRI-targeted prostate biopsies using transperineal vs transrectal approach
Please login below to download this issue (PDF)